Comparison of efficacy, safety, patients’ quality of life, and doctors’ occupational stress between lenalidomide‐based and bortezomib‐based induction in patients with newly diagnosed multiple myelomaLimei Xu, Juan Li, Jingli Gu et al.|Cancer Medicine|2021Cited by 11
Early monoclonal protein decline pattern is an independent prognostic factor in patients with multiple myelomaLimei Xu, Juan Li, Junru Liu et al.|Annals of Hematology|2020Cited by 6